Real world effectiveness of standard of care triple therapy versus two-drug combinations for treatment of people living with HIV

Ramón Teira(Hospital Sierrallana), Juan Berenguer(Instituto de Salud Carlos III), Vicente Estrada(Instituto de Salud Carlos III), Nadia Abdulghani(Hospital Universitari de Santa Maria), María Dolores Merino(Hospital Universitario Infanta Leonor), María José Muñoz(Research Institute Hospital 12 de Octubre), Helena Díaz-Cuervo(Gilead Sciences (Spain)), Sophie Marguet, Marta Montero, Alberto Romero-Palacios(Hospital Universitario Puerto Real), Peré Domingo(Hospital de Sant Pau), Elisa Martínez(University Hospital and Clinics), Elisabeth Deig(Hospital General de Granollers), Marcela Sepúlveda(Hospital Virgen de la Salud), Fernando Lozano(Hospital Universitario de Valme), Paloma Geijo(Hospital Virgen de la Luz), Filipa Aragão(Universidade Nova de Lisboa), Belén de la Fuente(Hospital Universitario De Cabueñes), Bernardino Roca(Hospital General Universitari de Castelló), Joaquim Peraire(Instituto de Salud Carlos III), Marı́a José Galindo(Hospital Clínico Universitario de Valencia), Esteban Ribera(Hospital Terrassa), Josefina García(Santa Lucía University General Hospital), Núria Espinosa
PLoS ONE
April 8, 2021
10.1371/journal.pone.0249515
Cited by 10

Related Papers

Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy
|JAMA|2016|1.4k
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study
|The Lancet|2019|1k
Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19
|JAMA|2021|728
Life expectancy after 2015 of adults with HIV on long-term antiretroviral therapy in Europe and North America: a collaborative analysis of cohort studies
|The Lancet HIV|2023|506
Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain
|Clinical Microbiology and Infection|2020|423